See you in Huntington Beach this summer! 🌴Make weekend plans to relax on the beach, catch up with peers, & most importantly, engage with experts on the latest update in #lungcancer !
Register here: bit.ly/3JrZ2c4
#CME #ILCC #lcsm David Gandara Roy Herbst Heather Wakelee

Re-Enrico Fermi, one of my favorite quotes of all time: “Before I came here today I was confused about this topic. Having listened to your lecture I am still confused. But on a higher level”. I admit that I have felt this way myself on occasion!

Join PER at the 25th Annual International Lung Cancer Congress for a groundbreaking symposium uniting top experts and healthcare professionals in the fight against lung cancer.

All giants are together OncoAlert

Solange Peters selected Lung Cancer Giant of Cancer Care 2024! I am asked to describe her in 3 words: Exceptional, Exceptional, Exceptional! There is a reason the NIH added this category as better than Outstanding. PER OncLive.com

The sheer number and rapid increase in the number of (often duplicative) mandatory online training modules for clinical care, research, and institutional employment is completely unsustainable ⁦AMA⁩ ama-assn.org/practice-manag…

Our breast CT scanner invented here at the #BooneLab continues to evolve. #IsoView , the newest version of the scanner, is showing a lot of promise. Find out the latest: ucdavis.health/3Ul70sD UC Davis Comprehensive Cancer Cent UC Davis Health UC Davis Research

Did you know, before 2003, the IASLC endorsed several meetings on Targeted Therapy of Lung Cancer, & then took over the conference management/program. Ever since, the IASLC #TTLC meeting has been held in California, during the month of February, on an annual basis! #IASLC50 #LCSM

Not one, not 2, but 3 lung cancer plenaries at #ASCO24 ! Early telemed pall care, the LAURA trial of consolidation osimertinib after CRT for stage 3 EGFR non small cell lung cancer & the ADRIATIC trial of consolidation immunotherapy after CRT for small cell lung cancer! #lcsm

#ISLB24 abstract submission open. Come one, come all. Denver Co, Nov 23-25. International Society of Liquid Biopsy Christian Rolfo

And so the advances continue in oncogene-driven NSCLC. FDA approves adjuvant alectinib in surgically resected early-stage ALK+ disease. In contrast to ADAURA, this result achieved without inclusion of chemotherapy. IASLC International Society of Liquid Biopsy

#CAMP24 Meeting Chair Diana Ionescu addresses potential issues with AI interpretation of pathologic specimens. Here, example of “noise constraint”, alegorically leading to misinterpretation of a pig as an airliner. Maybe pigs can fly after all! Lung Cancer Canada Association for Molecular Pathology

#CAMP24 (Canadian Anatomical & Molecular Pathology). such an enjoyable and educational experience. Here I am presented an “Honorary CAMP Pathologist” certificate by Chair, Diana Ionescu. Plus high tech! She recites a poem from Chat GPT to commemorate

Dr. Sandip Patel MD discusses Trop2 ADCs at #PLCClive24 . Sacituzumab govitecan and datopotamab deruxtecan both with some activity but how do they compare to docetaxel? Datopotamab with a good signal in non-squamous. No clear biomarker yet. MedscapeLIVE

Our recent publication clinically validating PROphet® #NSCLC is now the top feature in JCO Precision Oncology!

If you haven't read it yet, now's the time: ascopubs.org/doi/10.1200/PO…

#liquidbiopsy #proteomics #biomarker #precisiononcology

David Gandara Adam Dicker Chris Dingman ofer sharon

Yes, Alina trial changes SOC in resected ALK+ NSCLC. Remarkable that result achieved without chemotherapy.

The beginning of liquid biopsy in breast cancer. How an intuition became a revolution. International Society of Liquid Biopsy M JOSE SERRANO (LB&Cancer Interception group) Christian Rolfo David Gandara WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center #MBC #AACR24

EGFR mutants are not a monolithic entity. In fact EGFR mutational status is heterogeneous and EGFR mutated cancers can be Dr Jekyll or Mr Hyde #AACR24 Marina Garassino

👇🏾Delighted to chair this session today AACR #AACR24 .

“Biomarkers Predictive of Therapeutic Benefit”
📍Ballroom 6 CF Convention Center
Symposia • 3:00–5:00 pm

💡Beyond targeted therapies (HER2, KRASG12C) to predictive biomarkers of immunotherapy, toxicity➕ #ctDNA .

OncoAlert

Humbled for moderating a heated session on periop trial designs at AACR , with a great panel: Harpreet Singh, MD Raymond Osarogiagbon, MBBS, FACP Dr. Elizabeth Jaffee Michael Axelson Francesco Pignatti Manju George MVSc PhD Rectal Cancer Survivor Thank you all!